$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
How effective is the MET inhibitor capmatinib in non-small cell lung cancer?
2025-10-19 11:44:20
Check Details
Where can I buy the targeted drug capmatinib?
2025-10-19 11:44:20
Check Details
New drug for the treatment of metastatic non-small cell lung cancer-capmatinib
2025-10-19 11:44:20
Check Details
FDA approves lorlatinib for first-line treatment of ALK+ NSCLC, expanding its scope of application_ Kanghule
2025-10-19 11:44:20
Check Details
Is paclitaxel for injection reimbursed by medical insurance?
2025-10-19 11:44:20
Check Details
What does injectable paclitaxel (Abraxane) treat?
2025-10-19 11:44:20
Check Details
Where can I buy Tepotinib?
2025-10-19 11:44:20
Check Details
Tepotinib Instructions
2025-10-19 11:44:20
Check Details
Is tepotinib available in China?
2025-10-19 11:44:20
Check Details
Which company developed tepotinib?
2025-10-19 11:44:20
Check Details
Is lorlatinib tablets or capsules?
2025-10-19 11:44:20
Check Details
How much does lorlatinib cost per month to treat lung cancer?
2025-10-19 11:44:20
Check Details
1
2
...
3826
3827
3828
3829
3830
3831
3832
...
4152
4153
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Managing Immunotherapy-Related Adverse Events of Tarlatamab-Imdelltra: A Guide to Dual-Specific T Cell Engager Safety
2
Almonertinib Safety Guide: Managing Adverse Reactions in NSCLC Treatment with a 3rd-Gen EGFR TKI
3
Pimitespib Storage Guidelines: Temperature, Humidity & Light Control for Home Use
4
Cemiplimab (Libtayo) Drug Information
5
Mirvetuximab Soravtansine (Elahere): FRα-Targeted ADC for Platinum-Resistant Ovarian Cancer
6
The Cornerstone Therapy for Adrenocortical Carcinoma and Global Guidelines Update
7
Trodelvy® (Sacituzumab Govitecan-hziy): A Life-Changing ADC for Advanced Cancers
8
A Revolutionary Targeted Therapy for Hematological Malignancies
9
A New Option for Advanced Renal Cell Carcinoma Treatment
10
Trametinib (Mekinist): Precision MEK1/2 Inhibition Transforming Cancer Care Short Description:
11
Pirtobrutinib: A Novel BTK Inhibitor Offering Hope for Hematologic Cancer Patients Short Description:
12
Sacituzumab Govitecan: Trop-2 Targeted ADC Clinical Medication Guide